Recce Pharmaceuticals (Australia) Insiders

Recce Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (1.358) % which means that it has lost $1.358 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.7763) %, meaning that it generated substantial loss on money invested by shareholders. Recce Pharmaceuticals' management efficiency ratios could be used to measure how well Recce Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Recce Pharmaceuticals' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 15 M in 2026, whereas Non Current Liabilities Other is likely to drop slightly above 18.3 K in 2026. Common Stock Shares Outstanding is likely to gain to about 286.1 M in 2026, despite the fact that Net Loss is likely to grow to (18.3 M). Recce Pharmaceuticals owns a total of 289.18 Million outstanding shares. Recce Pharmaceuticals has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Dividends Paid is likely to drop to about 1.1 M in 2026. Common Stock Shares Outstanding is likely to gain to about 286.1 M in 2026, despite the fact that Net Loss is likely to grow to (18.3 M).

Recce Pharmaceuticals Workforce Comparison

The company has Profit Margin (PM) of (2.85) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (23.7) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $23.7.

Recce Pharmaceuticals Benchmark Summation

Recce Pharmaceuticals Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Recce Pharmaceuticals often depends on how effective the management is. Recce Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Recce management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Recce management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Recce Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Recce Pharmaceuticals. Check Recce Pharmaceuticals' Beneish M Score to see the likelihood of Recce Pharmaceuticals' management manipulating its earnings.

When running Recce Pharmaceuticals' price analysis, check to measure Recce Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recce Pharmaceuticals is operating at the current time. Most of Recce Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recce Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recce Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recce Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.